Published by Frank Prenesti on 27th December 2023
(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.
URL: http://www.digitallook.com/dl/news/story/33992091/...